Loading provider…
Loading provider…
Medical Oncology Physician in Saint Louis, MO
NPI: 1356652176Primary Practice Location
BARNES JEWISH HOSPITAL
1 Barnes Jewish Hospital Plz, Saint Louis, MO
Primary Employer
Washington University School of Medicine
surgery.wustl.edu
HQ Phone
Get MD Jeffrey's Phone Numberphone_androidMobile
Get MD Jeffrey's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardMO State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 96413Infusion of chemotherapy into a vein up to 1 hour | 62 | 101 |
| 2 | 96375Injection of different drug or substance into a vein for therapy, diagnosis, or prevention | 34 | 100 |
| 3 | 99214Established patient office or other outpatient visit, 30-39 minutes | 31 | 63 |
| 4 | 96367Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour | 31 | 56 |
| 5 | 99215Established patient office or other outpatient, visit typically 40 minutes | 30 | 48 |
Phase 1/dose expansion trial of brentuximab vedotin and lenalidomide in relapsed or refractory diffuse large B-cell lymphoma.
Authors: Kami Maddocks, Amanda Cashen, Nina Wagner-Johnston
Publication Date: 2021-03-28
Neoantigen-specific cytotoxic Tr1 CD4 T cells suppress cancer immunotherapy.
Authors: Sultan, Hussein, Takeuchi, Yoshiko, Ward, Jeffrey P, Sharma, Naveen, Liu, Tian-Tian, Sukhov, Vladimir, Firulyova, Maria, Song, Yuang, Ameh, Samuel, Brioschi, Simone, Khantakova, Darya, Arthur, Cora D, White, J Michael, Kohlmiller, Heather, Salazar, Andres M, Burns, Robert, Costa, Helio A, Moynihan, Kelly D, Yeung, Yik Andy, Djuretic, Ivana, Schumacher, Ton N, Sheehan, Kathleen C F, Colonna, Marco, Allison, James P, Murphy, Kenneth M, Artyomov, Maxim N, Schreiber, Robert D
Journal: Nature
Publication Date: 2024-07-24
Lead Sponsor: GlaxoSmithKline
Collaborators: iTeos Belgium SA
Intervention / Treatment: DRUG: Docetaxel, DRUG: Ipilimumab, DRUG: Dostarlimab, DRUG: GSK6097608, DRUG: Feladilimab, DRUG: GSK4428859A
Lead Sponsor: Washington University School of Medicine
Collaborators: AstraZeneca, Gateway for Cancer Research
Intervention / Treatment: DRUG: Durvalumab, PROCEDURE: Peripheral blood draws, BIOLOGICAL: Neoantigen DNA vaccine, DEVICE: TDS-IM v2.0 Device
Lead Sponsor: Washington University School of Medicine
Intervention / Treatment: DRUG: Paclitaxel, RADIATION: Radiation therapy, BIOLOGICAL: Durvalumab, DRUG: Carboplatin AUC, DEVICE: ViewRay MR-Linear Accelerator